Helvea

Type: Company
Name: Helvea
First reported Oct 24 2014 - Updated Oct 24 2014 - 1 reports

GlaxoSmithKline plc Upgraded by Barclays to Overweight (GSK)

GlaxoSmithKline plc (LON:GSK)Shares of GlaxoSmithKline plc (LON:GSK) traded up 2.54% during mid-day trading on Thursday, hitting GBX 1412.00. 13,915,501 shares of the company’s stock traded hands. GlaxoSmithKline plc has a 1-year low of GBX 1200.668 and ... [Published American Banking News - Oct 24 2014]
First reported Oct 22 2014 - Updated Oct 23 2014 - 1 reports

GlaxoSmithKline plc Announces Dividend of GBX 19 (GSK)

GlaxoSmithKline plc (LON:GSK) announced a dividend on Wednesday, October 22nd, StockRatingsNetwork reports. Investors of record on Thursday, November 6th will be paid a dividend of GBX 19 ($0.31) per share on Thursday, January 8th. This represents a dividend ... [Published American Banking News - Oct 22 2014]
First reported Oct 21 2014 - Updated Oct 22 2014 - 1 reports

GlaxoSmithKline plc Rating Reiterated by Baader Helvea (GSK)

Baader Helvea restated their hold rating on shares of GlaxoSmithKline plc (LON:GSK) in a research note issued to investors on Friday. The firm currently has a GBX 1,530 ($24.62) price target on the stock. GSK has been the subject of a number of other ... [Published Mideast Time - Oct 21 2014]
First reported Oct 15 2014 - Updated Oct 16 2014 - 1 reports

UPDATE 1-FDA approves two treatments from Roche, Boehringer for fatal lung disorder

disorder@ (Adds details, analyst comment)Oct 15 (Reuters) - The U.S. health regulator approved two treatments for use in idiopathic pulmonary fibrosis (IPF), marking its first-ever approvals for the fatal lung disease that has no clear etiology and no ... [Published CNBC - Oct 15 2014]
First reported Oct 15 2014 - Updated Oct 16 2014 - 1 reports

Shire shares plummet up to 29 percent as AbbVie says to reconsider deal

Shares in Shire fell as much as 29 percent Wednesday, the day after AbbVie said its board will meet to discuss withdrawing or modifying its planned $54.6-billion acquisition of the company due to recent changes to US regulations aimed at curbing tax inversions. ... [Published FirstWord Pharma - Oct 15 2014]
First reported Oct 15 2014 - Updated Oct 16 2014 - 2 reports

AbbVie Threat on Shire Deal Is Biggest Fallout to Tax Rules

(Updates with Shire response in fourth paragraph.)Oct. 15 (Bloomberg) -- AbbVie Inc. may scrap its planned 32.4-billion-pound ($51.5 billion) deal for Dublin-based drugmaker Shire Plc, in what would be the biggest casualty of the U.S. crackdown on so-called ... [Published Washington Post - Oct 15 2014]

Quotes

"While Esbriet is roughly $35,000 a year in Europe, the price could be double this in the U S " Morningstar analyst Karen Andersen said
...6-billion acquisition of the company due to recent changes to US regulations aimed at curbing tax inversions. "It's a strong sign these Treasury department rules are having an effect on these companies" remarked Helvea analyst Odile Rundquist, adding "without the tax benefits, the price is too high."

More Content

All (7) | News (7) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
GlaxoSmithKline plc Upgraded by Barclays to Ove... [Published American Banking News - Oct 24 2014]
GlaxoSmithKline plc Announces Dividend of GBX 1... [Published American Banking News - Oct 22 2014]
GlaxoSmithKline plc Rating Reiterated by Baader... [Published Mideast Time - Oct 21 2014]
AbbVie Threat on Shire Deal Is Biggest Fallout ... [Published Washington Post - Oct 15 2014]
UPDATE 1-FDA approves two treatments from Roche... [Published CNBC - Oct 15 2014]
Shire shares plummet up to 29 percent as AbbVie... [Published FirstWord Pharma - Oct 15 2014]
AbbVie Considers Ending $51.5 Billion Shire Dea... [Published Washington Post - Oct 15 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.